Townsquare Capital LLC Purchases 9,516 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Townsquare Capital LLC boosted its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 12.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 86,684 shares of the company's stock after buying an additional 9,516 shares during the quarter. Townsquare Capital LLC owned 0.18% of Prestige Consumer Healthcare worth $6,769,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Sterling Capital Management LLC boosted its position in shares of Prestige Consumer Healthcare by 837.1% in the 4th quarter. Sterling Capital Management LLC now owns 1,593 shares of the company's stock valued at $124,000 after purchasing an additional 1,423 shares during the period. Bessemer Group Inc. grew its stake in shares of Prestige Consumer Healthcare by 10,053.1% in the 4th quarter. Bessemer Group Inc. now owns 295,050 shares of the company's stock valued at $23,041,000 after buying an additional 292,144 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Prestige Consumer Healthcare in the fourth quarter worth approximately $42,593,000. Invesco Ltd. increased its position in Prestige Consumer Healthcare by 2.4% during the fourth quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock worth $82,796,000 after buying an additional 24,392 shares during the last quarter. Finally, Bank of Montreal Can increased its holdings in shares of Prestige Consumer Healthcare by 15.1% during the 4th quarter. Bank of Montreal Can now owns 7,127 shares of the company's stock valued at $557,000 after acquiring an additional 937 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors.

Insider Activity

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the sale, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.60% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Canaccord Genuity Group boosted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Royal Bank of Canada boosted their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a research report on Friday, March 21st. DA Davidson raised their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Oppenheimer boosted their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Finally, StockNews.com lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Tuesday, April 8th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $93.33.

Prestige Consumer Healthcare Stock Performance

PBH traded up $0.30 on Friday, hitting $80.10. 292,350 shares of the stock traded hands, compared to its average volume of 286,757. The business has a fifty day moving average price of $84.16 and a two-hundred day moving average price of $80.09. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $3.97 billion, a PE ratio of 18.76, a P/E/G ratio of 2.69 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.